Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicagrel in ACS Patients Undergoing PCI
NCT06577519Phase 3Recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vicagrel in acute coronary syndrome (ACS), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Sep 2024; status: recruiting.
02
Drugs
vicagrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06577519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06577519.